Answers are grounded in this paper and cite their sources.
In contrast to LDL cholesterol (LDL-C), HDL-C correlates with cardiovascular risk only in healthy individuals. The calculation of the ratio of LDL-C to HDL-C is not useful for all patients. Low HDL-C should prompt examination of additional metabolic and inflammatory pathologies. An increase in HDL-C through lifestyle change (smoking cessation, physical exercise) has positive effects and is recommended. However, HDL-C is currently not a valid target for drug therapy.
No takes yet. Share an insight, caveat, or question.
März et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: